Insider Buying: Argenica Therapeutics Limited (ASX:AGN) Insider Purchases A$251,363.78 in Stock

Argenica Therapeutics Limited (ASX:AGN – Get Free Report) insider Terrence (Terry) Budge purchased 318,182 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The shares were bought at an average price of A$0.79 ($0.52) per share, with a total value of A$251,363.78 ($165,370.91). Argenica Therapeutics Stock Performance Argenica Therapeutics Company […]

Leave a Reply

Your email address will not be published.

Previous post Legend Biotech (NASDAQ:LEGN) Given Buy Rating at HC Wainwright
Next post Pacira BioSciences’ (PCRX) “Underweight” Rating Reaffirmed at JPMorgan Chase & Co.